Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

A specific proteinase 3 activity footprint in α1-antitrypsin deficiency.

Newby PR, Crossley D, Crisford H, Stockley JA, Mumford RA, Carter RI, Bolton CE, Hopkinson NS, Mahadeva R, Steiner MC, Wilkinson TMA, Sapey E, Stockley RA.

ERJ Open Res. 2019 Aug 5;5(3). pii: 00095-2019. doi: 10.1183/23120541.00095-2019. eCollection 2019 Jul.

2.

The Relationship of the Fibrinogen Cleavage Biomarker Aα-Val360 With Disease Severity and Activity in α1-Antitrypsin Deficiency.

Carter RI, Ungurs MJ, Pillai A, Mumford RA, Stockley RA.

Chest. 2015 Aug;148(2):382-388. doi: 10.1378/chest.14-0520.

PMID:
25569856
3.
4.

Trainee concerns regarding the Specialty Certificate Examination: results of a British Thoracic Society national survey.

Patterson CM, Carter RI, Dodd JW, Collins A.

Thorax. 2014 Jan;69(1):85-6. doi: 10.1136/thoraxjnl-2013-204306. Epub 2013 Aug 23. No abstract available.

PMID:
23976780
5.

Aα-Val360: a marker of neutrophil elastase and COPD disease activity.

Carter RI, Ungurs MJ, Mumford RA, Stockley RA.

Eur Respir J. 2013 Jan;41(1):31-8. doi: 10.1183/09031936.00197411. Epub 2012 Apr 20.

6.

The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo.

Carter RI, Mumford RA, Treonze KM, Finke PE, Davies P, Si Q, Humes JL, Dirksen A, Piitulainen E, Ahmad A, Stockley RA.

Thorax. 2011 Aug;66(8):686-91. doi: 10.1136/thx.2010.154690. Epub 2011 May 26.

PMID:
21617168

Supplemental Content

Loading ...
Support Center